Corixa Corp. said it restructured its South San Francisco operations by reducing its work force there by about 60 percent, and completed a $21 million deal with Medarex Inc. to sell certain technology and preclinical therapeutic programs. (BioWorld Today)

Corixa Corp. said it restructured its South San Francisco operations by reducing its work force there by about 60 percent, and completed a $21 million deal with Medarex Inc. to sell certain technology and preclinical therapeutic programs. (BioWorld Today)